Navigation Links
NxStage to Present at the Cowen and Company 29th Annual Healthcare Conference

LAWRENCE, Mass., March 10 /PRNewswire-FirstCall/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that Jeffrey H. Burbank, Chief Executive Officer, will be presenting at the Cowen and Company 29th Annual Healthcare Conference on Monday, March 16, 2009 at the Marriot Copley Place in Boston, MA.

NxStage's investor presentation is scheduled for Monday, March 16th at 4:40 p.m. ET. To listen to the audio webcast of the presentation, please visit:

About NxStage

NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. For more information on NxStage and its products, please visit the company's website at

Forward-Looking Statements

This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," and similar expressions are generally intended to identify forward-looking statements. Examples of these forward-looking statements include statements as to Mr. Burbank's plans to present at this conference. NxStage specifically disclaims any obligation to update these forward-looking statements. These forward-looking statements should not be relied upon as representing NxStage's expectations or beliefs as of any date subsequent to the date of this press release.

    Kristen K. Sheppard, Esq.
    Investor Relations

SOURCE NxStage Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. NxStage to Present at the JPMorgan Healthcare Conference
2. NxStage Announces Streamline(TM) Blood Tubing Set Supply Agreement with Renal Advantage Inc.
3. NxStage Medical to Present at JMP Securities Healthcare Focus Conference
4. NxStage Announces Investor Conference Schedule
5. NxStage Announces Access to Demographic and Outcomes Information for the Growing U.S. Daily Home Hemodialysis Patient Population
6. NxStage Medical to Present at William Blair Growth Stock Conference
7. NxStage Appoints Tom Shea as Senior Vice President of Manufacturing Operations
8. NxStage Medical Announces Needle Supply Agreement with DaVita
9. NxStage Medical to Present at the Piper Jaffray Healthcare Conference on November 27, 2007
10. Arbios Announces SEPET(TM) Manufacturing Agreement With NxStage Medical
11. NxStage(R) Medical to Report Third Quarter 2007 Financial Results on Friday, November 2nd
Post Your Comments:
(Date:11/30/2015)... ... November 30, 2015 , ... Global Stem Cells Group ... professionals from Central America and abroad for the first Iberoamerican Convention on Aesthetic ... 17-19, 2016. Testart will present and discuss new trends in anti-aging stem cell ...
(Date:11/30/2015)... radiology technique shows promise for helping morbidly obese patients lose ... presented today at the annual meeting of the Radiological Society ... --> --> Gastric artery embolization ... way to stop bleeding in emergency situations, but the idea ... is new. Mubin Syed , M.D., interventional radiologist ...
(Date:11/30/2015)... 30, 2015 Harvard Apparatus Regenerative Technology, ... company developing bioengineered organ implants for life-threatening conditions, ... The NASDAQ Stock Market that it has regained ... letter noted that as a result of the ... exceeded $1.00 per share for more than ten ...
(Date:11/30/2015)...  Champions Oncology, Inc. (CSBR), engaged in the development ... development and use of oncology drugs, today announced that ... presenting at the LD MICRO Investor Conference on Wednesday, ... The conference, held at the Luxe Sunset Bel Air ... will feature 200 small/micro-cap companies and is expected to ...
Breaking Biology Technology:
(Date:11/10/2015)... 2015  In this report, the biomarkers ... product, type, application, disease indication, and geography. ... are consumables, services, software. The type segments ... efficacy biomarkers, and validation biomarkers. The applications ... development, drug discovery and development, personalized medicine, ...
(Date:11/9/2015)... DUBLIN , Nov. 09, 2015 /PRNewswire/ ... announced the addition of the "Global ... to their offering. --> ... "Global Law Enforcement Biometrics Market 2015-2019" ... Research and Markets ( ) ...
(Date:11/4/2015)... ALBANY, New York , November 4, 2015 /PRNewswire/ ... According to a new market report published by Transparency ... Size, Share, Growth, Trends and Forecast 2015 - 2022", ... value of US$ 30.3 bn by 2022. The market ... during the forecast period from 2015 to 2022. Rising ...
Breaking Biology News(10 mins):